Economic burden of chronic respiratory diseases in Austria and Slovenia: Results of a life-cycle model

Pock, Markus; Czypionka, ThomasORCID: https://orcid.org/0000-0002-3381-1075; Reiss, MiriamORCID: https://orcid.org/0000-0002-7009-7341 and Röhrling, Gerald (April 2018) Economic burden of chronic respiratory diseases in Austria and Slovenia: Results of a life-cycle model. [Research Report] 129 p.

[img]
Preview
Text
2018-ihs-report-pock-czypionka-reiss-copd-chronic-respiratory-diseases-austria-slovenia.pdf - Published Version

Download (4MB) | Preview

Abstract or Table of Contents

This study estimates the economic burden of chronic respiratory diseases (CRD) in Austria and Slovenia. The two dominant CRD are COPD and asthma. Using publicly accessible data sources, the cost categories are divided into direct medical, direct non-medical and indirect costs. Within the framework of a life-cycle model, we estimated the annual burden of CRD in the year 2014 at EUR 508.1 million (or 0.15% of GDP) in Austria and EUR 34.2 million (or 0.09% of GDP) in Slovenia.

Item Type: Research Report
Additional Information (public): In collaboration with: VI vis d.o.o., Slovenia, Scientific Advisory Boards of Austria and Slovenia
Funders: GSK - GlaxoSmithKline Pharma GmbH
Research Units: Health Economics and Health Policy
Date Deposited: 07 May 2018 09:01
Last Modified: 20 Feb 2020 11:06
URI: https://irihs.ihs.ac.at/id/eprint/4663

Actions (login required)

View Item View Item